Cargando…
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
OBJECTIVE: To determine whether assessment tools for non-randomised studies (NRS) address critical elements that influence the validity of NRS findings for comparative safety and effectiveness of medications. DESIGN: Systematic review and Delphi survey. DATA SOURCES: We searched PubMed, Embase, Goog...
Autores principales: | D'Andrea, Elvira, Vinals, Lydia, Patorno, Elisabetta, Franklin, Jessica M., Bennett, Dimitri, Largent, Joan A., Moga, Daniela C., Yuan, Hongbo, Wen, Xuerong, Zullo, Andrew R., Debray, Thomas P. A., Sarri, Grammati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993210/ https://www.ncbi.nlm.nih.gov/pubmed/33762237 http://dx.doi.org/10.1136/bmjopen-2020-043961 |
Ejemplares similares
-
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
por: Sarri, Grammati, et al.
Publicado: (2022) -
ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs
por: Sarri, Grammati, et al.
Publicado: (2022) -
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature
por: Wyss, Richard, et al.
Publicado: (2022) -
Can Real-World Evidence Help Restore Decades of Health Inequalities by Informing Health Care Decision-Making? Certainly, and Here is How
por: Sarri, Grammati
Publicado: (2022) -
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2020)